Skip to main content

Table 4 Five year local control rates from studies employing hypofractionated radiotherapy for T1N0 and T20 squamous cell carcinoma of the glottis

From: Definitive hypofractionated radiotherapy for early glottic carcinoma: experience of 55Gy in 20 fractions

Author/year

No. of patients

Dose (5 days/week daily fractionation unless stated)

Fraction size

OTT

tBED

Follow up/years

5 year LC T1a

5 year LC T1b

5 year LC T2

Current series

132 (n = 68 T1)

55Gy in 20

2.75

26

67.0

6

91.8 %

81.6 %

80.9 %

Moon et al. 2014 [26]

156 (n = 139 T1)

RCT:

   

5.6

5 years Local PFS

Conventional arm (n = 82):

    

T1/2:

77.8 % conv

66 in 33 for T1

2Gy

44

62.3

 

88.5 % hypo

70Gy in 35 for T2

 

47

64.7

  

Hypofractionated arm (n = 74):

    

T1 only:

 

80.3 % conv

 

63Gy in 28 (T1) 67.5Gy in 30 for T2

2.25Gy

38

64.9

 

90.1 % hypo

 

40

68.8

   

T1a only: 76.7 % conv

  

93 % hypo

  

Kim et al. 2012 [27]

157 (n=125 T1 only)

70Gy in 35 (n = 64 pts)

2Gy

47

64.7

7.1

All T1

83 %

63 %

67.5Gy in 30 (n = 93)

2.25Gy

40

68.8

3.8

95 %

61 %

Laskar et al. 2012 [28]

652 (T1 only)

50Gy in 15

3.3Gy

19

68.9

5

All T1: 90.6 % >3Gy per fraction 86.8Gy <3Gy per fraction (NS difference between fractionation schedules)

 

55Gy in 16

3.43Gy

22

73.9

60Gy in 24

2.5Gy

32

67.3

62.5 in 25

2.5Gy

33

69.6

Jamshed et al. 2011 [30]

87 (n = 83 T1)

55Gy in 20

2.75

26

67.0

2.6

LRC 95 %

LRC 88 %

n/a

Chera et al. 2009 [16]

585 (n = 325)

63Gy in 28 (T1)

2.25Gy

38

64.9

12

94 %

93 %

T2a 80 %

65.25Gy in 29 (T2)

39

66.8

T2b 70 %

(39 % of series includes other schedules including hyperfractionation)

Cheah et al. 2009 [11]

100 (T1 only)

50Gy in 16 fractions

3.125Gy

22

65.6

7

90 %

85 %

N/A

Short et al. 2006 [29]

145 (n = 102 T1)

60–66Gy in 30–33 (n = 51)

2

40–44

58.1–62.3

4.9

All T1 LRC 75 % conv

LRC 80 % (conv)

52.5-55Gy in 20 (n = 94)

2.625–2.75

26

63.2–67.0

LRC 91 % hypo

LRC 81 % (hypo)

Yamazaki et al. 2006 [8]

180 (T1 only)

RCT: 60–66Gy in 30–33

   

Not stated

All T1

  

(66Gy if >2/3 of cord) (n = 89)

2Gy

40–44

58.1–62.3

 

LC 77 % conv

  

56.25Gy in 25 or 63Gy in 28 (>2/3cord) (n = 91)

2.25Gy

33–38

60.4–64.9

 

LC 92 % hypo

  

Gowda 2003 [12]

200 (T1 only)

50–52.5Gy in 16

3.12–3.28Gy

22

65.6–68.7

5.8

93.1 %

89.1 %

 
  1. Conv = conventional fractionation
  2. Hypo = hypofractionated
  3. LC = local control
  4. LRC = locoregional control
  5. OTT = overall treatment time
  6. PFS = progression free survival
  7. tBED = tumour biologically effective dose